2024
Release time：2024-04-30 10:52
GT20029 Phase II Clinical Trial for Treatment of ACNE in China Completed First Subject Enrollment
KX-826 Received The INCI Designation
KX-826 Tincture 1.0% Clinical Trial For The Treatment Of Male Adult AGA In China Received Clearance By NMPA
GT20029 Phase II Clinical Trial for Treatment of AGA in China Reached Primary Endpoint
KX-826 Phase Ib/III Clinical Trial of Combination Therapy with Minoxidil For The Treatment of Male AGA Received Clearance by China NMPA
recommend News
2025-06-25
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn